Side-ffects 15 Years after Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925.
Fiche publication
Date publication
juillet 2021
Journal
Journal of the National Cancer Institute
Auteurs
Membres identifiés du Cancéropôle Est :
Pr NOEL Georges, Dr PEIGNAUX Karine
Tous les auteurs :
Poortmans PM, Struikmans H, De Brouwer P, Weltens C, Fortpied C, Kirkove C, Budach V, Peignaux-Casasnovas K, van der Leij F, Vonk E, Valli M, van Tienhoven G, Weidner N, Noel G, Guckenberger M, Koiter E, van Limbergen E, Engelen A, Fourquet A, Bartelink H,
Lien Pubmed
Résumé
Uncertainty about the benefit/risk ratio of regional lymph node irradiation led to varying clinical protocols. We investigated long-term late side effects after internal mammary and medial supraclavicular (IM-MS) lymph node irradiation to improve shared decision-making.
Mots clés
Breast cancer, EORTC, Lymph nodes, Radiotherapy, Randomized trial, side effects, toxicity
Référence
J Natl Cancer Inst. 2021 Jul 28;: